Pdi Therapeutics

Antibody inhibitors to a specific protein disulfide isomerase to improve recognition of tumor cells by the adaptive immune response

placeSan Diego, California, United States calendar_todayFounded 2016 language pditherapeutics.com

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 22 times.

YearFilings
20191
20202
20212

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon